| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.32 | 2e-09 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.25 | 2e-08 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.2 | 7e-06 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.23 | 4e-05 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.17 | 6e-05 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.16 | 9e-05 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0002 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | -0.15 | 0.0002 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | 0.15 | 0.0002 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0003 |